Karen Dieterle

Karen Dieterle has a diverse work experience spanning over two decades. Karen currently holds the position of Sr. Director, Project Management at Avalo Therapeutics since January 2022. Prior to this, they served as the Director of Project Management at Avalo Therapeutics from January 2021 to March 2022.

From 2016 to 2021, Karen worked as a Senior Project Manager at CSL Behring. In this role, they were responsible for program management of a complex rare disease portfolio in Transplant. Karen also collaborated with Global R&D Team Leaders to establish strategies, goals, and timelines for the portfolio.

In 2015, Karen worked as an R&D Program Manager at Shire Pharmaceuticals (Consultant). Karen provided program management expertise for multiple global cross-functional late-stage clinical development teams in the Neuroscience Business Unit.

From 2013 to 2014, Karen held the role of Head, External Interface Office, Global Medicines Development Operations at AstraZeneca. Karen led, managed, and provided strategic direction to three departmental functions.

Additionally, from 2007 to 2013, Karen worked as the Director, Chief Medical Office (CMO) Operations at AstraZeneca. Karen played a crucial role in developing and structuring the operational capabilities within the CMO.

Furthermore, Karen's early experience includes working as a Clinical Project Manager at AstraZeneca from 2000 to 2007. Karen managed the delivery of Phase IIIB Asthma and Chronic Obstructive Pulmonary Disease (COPD) Programs for Symbicort and led a clinical cross-functional team.

Overall, Karen Dieterle has a strong background in project management, strategic planning, and cross-functional leadership within the pharmaceutical industry.

Karen Dieterle completed their Bachelor of Arts degree in International Management and French at Moravian University from 1990 to 1994. Later on, they pursued a Masters of Business Administration at Penn State University, which they completed in 2003.